Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

Melanoma and Skin Cancer

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial

Lancet

Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, Morano F, Roy A, Dahan L, Tamberi S, Dhadda AS, Saunders MP, Casanova N, Guimbaud R, Lievre A, Maurel J, Fakih M, Tian C, Harrison J, Jones MM, Cornfeld M, Spano JP, Rochefort P, POD1UM-303/InterAACT-2 study investigators

doi: 10.1016/S0140-6736(25)00631-2

Melanoma and Skin Cancer

Radiologic Imaging Aids Management of High-risk Cutaneous Squamous Cell Carcinoma: A Retrospective Cohort Study

J Am Acad Dermatol

Wei AH, Cassard L, Fan C, Seck S, Vazquez MR, Bena J, Stultz T, Koyfman SA, Vidimos AT

doi: 10.1016/j.jaad.2025.04.028

Autoimmune Disease

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial

JAMA

Thouvenot E, Laplaud D, Lebrun-Frenay C, Derache N, Le Page E, Maillart E, Froment-Tilikete C, Castelnovo G, Casez O, Coustans M, Guennoc AM, Heinzlef O, Magy L, Nifle C, Ayrignac X, Fromont A, Gaillard N, Caucheteux N, Patry I, De Sèze J, Deschamps R, Clavelou P, Biotti D, Edan G, Camu W, Agherbi H, Renard D, Demattei C, Fabbro-Peray P, Mura T, Rival M, D-Lay MS Investigators

doi: 10.1001/jama.2025.1604

Melanoma and Skin Cancer

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

JAMA Dermatol

Ran NA, Granger EE, Brodland DG, Cañueto J, Carr DR, Carter JB, Carucci JA, Hirotsu KE, Koyfman SA, Mangold AR, Girardi FM, Shahwan KT, Srivastava D, Vidimos AT, Willenbrink TJ, Wysong A, Ruiz ES

doi: 10.1001/jamadermatol.2025.0128

Melanoma and Skin Cancer

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Br J Dermatol

Laimer M, South AP, Mayr E, Kitzmueller S, Banner L, Alexander M, Hosler L, Yang H, Parris M, Arora M, Zimmermann G, Schweighofer-Zwink G, Bauer JW, Nikbakht N

doi: 10.1093/bjd/ljaf205

Melanoma and Skin Cancer

Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas

J Am Acad Dermatol

Thompson KG, Tripathi R, Jedrych J, Bibee KP, Scott JF, Ng E

doi: 10.1016/j.jaad.2024.08.018

Autoimmune Disease

A systematic review of clinical trial designs and outcome measures in Sjögren's disease randomized trials

J Rheumatol

Beydon M, Nguyen Y, Gordon R, Foulquier N, Bouillot C, Hammitt KM, Bowman SJ, Mariette X, Cornec D, McCoy SS, Seror R

doi: 10.3899/jrheum.2024-1012

Further Publications DermatologyFurther Publications Immunology

Human Papillomavirus Vaccination and Actinic Keratosis Burden: The VAXAK Randomized Clinical Trial

JAMA Dermatol

Wenande E, Hastrup A, Wiegell S, Philipsen PA, Thomsen NB, Demehri S, Kjaer SK, Haedersdal M

doi: 10.1001/jamadermatol.2025.0531

Psoriasis

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial

JAMA Dermatol

McMichael A, Shahriari M, Stein Gold L, Alkousakis T, Choi O, Bhutani T, Rodriguez AO, Tyring SK, Chan D, Rowland K, Albrecht L, Lynde C, Yadav G, Yeung J, Park-Wyllie L, Ma T, Jeyarajah J, Gao LL, Smith S, Moore AY, Vashi N, Kindred C, Grimes P, Desai SR, Taylor SC, Alexis A, VISIBLE Trial Investigators

doi: 10.1001/jamadermatol.2025.1849

Related content

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial

Radiologic Imaging Aids Management of High-risk Cutaneous Squamous Cell Carcinoma: A Retrospective Cohort Study

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas

A systematic review of clinical trial designs and outcome measures in Sjögren's disease randomized trials

Human Papillomavirus Vaccination and Actinic Keratosis Burden: The VAXAK Randomized Clinical Trial

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial